PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 46 filers reported holding PASSAGE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,842,000 | -26.2% | 290,213 | -2.5% | 0.13% | -27.2% |
| Q1 2021 | $5,204,000 | +47.3% | 297,713 | +115.5% | 0.17% | +40.7% |
| Q4 2020 | $3,533,000 | -17.5% | 138,161 | -57.7% | 0.12% | -35.3% |
| Q3 2020 | $4,285,000 | -52.0% | 326,873 | 0.0% | 0.19% | -55.0% |
| Q2 2020 | $8,933,000 | +76.7% | 326,873 | +1.8% | 0.42% | +33.1% |
| Q1 2020 | $5,056,000 | – | 321,013 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $15,375,000 | 15.35% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $3,831,000 | 4.65% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $7,744,000 | 3.82% |
| Frazier Life Sciences Management, L.P. | 5,009,219 | $15,529,000 | 1.32% |
| Deep Track Capital, LP | 3,375,000 | $10,463,000 | 0.67% |
| Orbimed Advisors | 7,331,999 | $22,729,000 | 0.37% |
| Lynx1 Capital Management LP | 105,504 | $327,000 | 0.30% |
| XTX Topco Ltd | 94,309 | $292,000 | 0.13% |
| Woodline Partners LP | 1,913,880 | $5,933,000 | 0.10% |
| GREAT POINT PARTNERS LLC | 113,900 | $353,000 | 0.08% |